28.02.2019
- Swiss drugs giant Roche has agreed to pay $4.3 billion for Spark Therapeutics, marking the latest purchase of a biotech company by big pharma. The deal gives Roche the first US...
11.12.2018
- Gilead Sciences has nabbed Daniel O’Day, head of Roche’s pharma business, as its new chief executive to replace current CEO John Milligan, with effective from March 2019. Both...
05.12.2018
- A new type of cancer treatment developed by a partnership of Bayer with biotech partner Loxo Oncology has won approval from the US Food and Drug Administration (FDA). Vitrakvi is...
19.09.2018
- With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service...
04.09.2018
- German biopharma Affimed has agreed a strategic collaboration with Genentech, part of Swiss drug giant Roche, to develop immunotherapies for multiple cancers. Affimed will apply...
26.07.2018
- Swiss pharmaceutical giant Roche has signed up to a multi-year collaboration with PureTech Health, a US clinical stage biopharma focused on the brain-immune-gut axis. The partners...
20.06.2018
- Swiss drugmaker Roche is paying $2.4 billion to acquire the rest of the shares it does not already own in US molecular and genomic analysis company Foundation Medicine (FMI). The...
05.06.2018
- The digital developments in the healthcare industry, combined with an aging population and enormous scientific progress, pose new challenges for pharmaceutical companies. On the...
